Clovis Oncology, Inc. announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the Barclays Global Healthcare Conference on Tuesday, March 10, 2020 at 11:15 a.m. Eastern time.
BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the Barclays Global Healthcare Conference on Tuesday, March 10, 2020 at 11:15 a.m. Eastern time. The conference will be held at the Loews Miami Beach Hotel in Miami.
A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005105/en/
Anna Sussman
303.625.5022
asussman@clovisoncology.com
Breanna Burkart
303.625.5023
bburkart@clovisoncology.com
Source: Clovis Oncology
View this news release online at:
http://www.businesswire.com/news/home/20200303005105/en